Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 018901/0587 | |
| Pages: | 6 |
| | Recorded: | 02/16/2007 | | |
| Attorney Dkt #: | P2026R1P1 |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE CO-ASSIGNEE, NOVARTIS AG. A CORPORATION ORGANIZED AND EXISTING UNDER AND BY VIRTUE OF THE LAWS OF SWITZERLAND, PREVIOUSLY RECORDED ON REEL 017122 FRAME 0033. ASSIGNOR(S) HEREBY CONFIRMS THE GENENTECH, INC. WAS NAMED AS THE SOLE ASSIGNEE. |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
11013966
|
Filing Dt:
|
12/16/2004
|
|
Publication #:
|
|
Pub Dt:
|
07/21/2005
| | | | |
|
Title:
|
Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations
|
|
|
Assignees
|
|
|
|
|
| 1 DNA WAY |
| M/S 49 |
| SO. SAN FRANCISCO, CALIFORNIA 94080-4990 |
|
|
|
|
|
| LICHSTRASSE 35 |
| BASEL, SWITZERLAND CH-4056 |
|
|
Correspondence name and address
|
| |
GENENTECH, INC.
|
| |
1 DNA WAY
|
| |
CRAIG G. SVOBODA
|
| |
SO. SAN FRANCISCO, CA 94080-4990
|
Search Results as of:
05/15/2024 01:07 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
